Our findings suggest that IGF-I/IR genetic variants interact with obesity, physical activity, and exogenous E, altering postmenopausal CRC risk, through IGF-I/IR traits, but also through different pathways. The gene discussed is IGF1; the disease is obesity due to melanocortin 4 receptor deficiency.